ATC Group: D07XB02 Triamcinolone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D07XB02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D07 Corticosteroids, dermatological preparations
3 D07X Corticosteroids, other combinations
4 D07XB Corticosteroids, moderately potent, other combinations
5 D07XB02 Triamcinolone

Active ingredients in D07XB02

Active Ingredient Description
Triamcinolone

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.

Medicines in this ATC group

Australia (AU)

France (FR)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.